Clinical profile and management of patients with pediatric inflammatory multisystem syndrome – temporally associated with SARS-CoV-2 – single-center experience
| dc.contributor.author | Opalińska-Zielonka, Paulina | |
| dc.contributor.author | Wiącek, Katarzyna | |
| dc.contributor.author | Marczak, Paweł | |
| dc.contributor.author | Piasecka, Krystyna | |
| dc.contributor.author | Korczowski, Bartosz | |
| dc.date.accessioned | 2022-04-12T09:15:09Z | |
| dc.date.available | 2022-04-12T09:15:09Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Introduction and aim. Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) is a new condition that has emerged in children during the COVID-19 pandemic. Many clinical signs and symptoms resemble those found in Kawasaki disease (KD). Material and methods. The following data were considered: clinical presentation, comorbidities, laboratory findings, abnormalities in additional tests, exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the child and his family members, applied treatment and return to full health. Results. In the presented study nineteen children were analyzed. Fever was a universal finding in our group and it’s mean duration was 7 days (range 5-9). Other common symptoms included abdominal pain and severe weakness (in 89.5%), rash and conjunctivitis (in 84.2%), vomiting (in 73.7%) and mucous membrane involvement (in 63.2%). In nearly half of cases, echocardiography revealed fluid in the pericardial sac and left ventricular systolic dysfunction (in 52.6% and 47.4% respectively). 21.1% of patients had coronary artery abnormalities. 26,3% of the children required treatment with dopamine and/or milrinone. In 15.7% ICU admissions and assisted ventilation was necessary. No deaths were recorded. Conclusion. One should bear in mind that PIMS-TS can mimic KD, appendicitis and meningitis, which may pose a diagnostic challenge. | pl_PL.UTF-8 |
| dc.identifier.citation | European Journal of Clinical and Experimental Medicine T. 20, z. 1 (2022), s. 11–17 | pl_PL.UTF-8 |
| dc.identifier.doi | 10.15584/ejcem.2022.1.2 | |
| dc.identifier.eissn | 2544-1361 | |
| dc.identifier.uri | http://repozytorium.ur.edu.pl/handle/item/7594 | |
| dc.language.iso | eng | pl_PL.UTF-8 |
| dc.publisher | Wydawnictwo Uniwersytetu Rzeszowskiego | pl_PL.UTF-8 |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | COVID-19 | pl_PL.UTF-8 |
| dc.subject | KawaCOVID | pl_PL.UTF-8 |
| dc.subject | Kawasaki disease PIMS-TS | pl_PL.UTF-8 |
| dc.subject | MIS-C | pl_PL.UTF-8 |
| dc.subject | SISCoV | pl_PL.UTF-8 |
| dc.title | Clinical profile and management of patients with pediatric inflammatory multisystem syndrome – temporally associated with SARS-CoV-2 – single-center experience | pl_PL.UTF-8 |
| dc.type | article | pl_PL.UTF-8 |